Navigation Links
FDA Stem Cell Approval Breakthrough Laudable
Date:1/23/2009

SAN CLEMENTE, Calif., Jan. 23 /PRNewswire/ -- Today the FDA announced approval for the first clinical trials on humans using Embryonic Stem Cells but Adult Stem Cell scientist Christian Drapeau says the experts may not be telling the whole story; Adult Stem Cells have greater potential with less risk.

"While the FDA approval is an exciting step forward toward freeing science from the shackles of politics," said Drapeau. "The expert commentary we're seeing surrounding the FDA's action is misleading."

Christian Drapeau, an early advocate of ASC science, posits that ACS are showing the greatest potential for scientific and medical advances.

Drapeau says that ASC can be a safer alternative to Embryonic Stem Cells because of a lower risk of tumor formation while studies show ASC to have comparable potential or even more in repairing damaged tissues or organs. This contradicts experts on morning talk shows who cast doubt on the efficacy of ACS research.

"The use of ASC requires a different thinking, but they can be as effective as ESC, if not more. ASC do not grow easily in vitro and they are not easy to re-program. But there are ways of using ASC that can be just as effective as methods using ESC, without the risk of tumor formation."

"Adult Stem Cells are showing great promise," notes Drapeau. "This is a very very important area of research right now and people must realize that Embryonic Stem Cells are not the only Stem Cell phenomenon out there."

"The scientific community is rejoicing today as a new age of medicine is ushered in concurrent with the Obama administration but the possibilities of Adult Stem Cell science are so mind boggling in terms of healing physical damage and the elimination of disease that the scientific community must focus on what works best, with the least amount of risk and the greatest scope of application," said Drapeau.


'/>"/>
SOURCE Christian Drapeau
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
3. CryoCor Receives FDA Approval for Right Atrial Flutter
4. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
7. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
8. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
9. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
10. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
11. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RRY HILL, N.J., Dec. 1 F...rprised and delighted when his radiotherapy treatm...0 minutes each day to less than five. Midway thro...are Valley Urology Cancer Center acquired the re...gy from Varian Medical Systems (NYSE: VAR ), ma...
(Date:12/1/2009)... Calif., Dec. 1 The new position o...Microchip Biotechnologies, Inc. has been taken up ...ve with more than 30 years of experience creating ...r. Goldstein will direct Microchip Biotechnologies...mer service operations as the company makes the tr...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 1First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 2First Pediatric Patient Treated With Aptocine 28TM 29 a Novel Light Activated Drug in Neurofibromatosis Study 13528 3Sage Software Healthcare Inc Celebrates National Health Center Week 54311 1Sage Software Healthcare Inc Celebrates National Health Center Week 54311 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 1Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 2Goold Health Systems Accelerates Backups by 5 times Using Arkeia Network Backup 54309 3
...allisto Pharmaceuticals,Inc. (Amex: KAL; FWB: CA4)...against cancer and inflammatory diseases, announce...clinical trial of Atiprimod to treat low to,interm...rcinoid cancer).,With the addition of the Robert H...n University, 676 N. St. Clair Street, Suite 850, ...
... Give Molecular Laboratories Increased Efficiencie... Test, Which Surpasses, Standard-of-Care Sensitiv... Measure All Known Strains of HIV-1,...has received a supplemental Premarket Approval fro...cently introduced RealTime HIV-1 viral load test.,...
Other Medicine Technology:Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 2Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 3Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 2Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 3Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 4Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 5Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test 6
(Date:12/1/2009)...easingly common but more easily identified, study ...s) -- A magnetic resonance imaging test is highly...cy complication called placenta accreta, researche...enta surrounding a fetus attaches too deeply to a ...pull out parts of the uterine wall, rupturing bloo...
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...
(Date:12/1/2009)...NS, Dec. 1 The American...professional association of blood specialists, exp...nual Meeting from December 5-8, 2009, at the Ernes...The meeting will showcase the latest research and ...leasure to host ASH,s 51st annual meeting, where w...
(Date:12/1/2009)...TON, Dec. 1 On December...,538 federal prisoners were HIV positive or had co...S) in the Office of Justice Programs, U.S. Departm...an estimated 5,672 inmates in state and federal pr... In 2007, about 43 per 10,000 prison inmates were ...
(Date:12/1/2009)...evelopment of simple screening test, expert says ,...n a finding that could lead to a simple blood test...identified immune system markers that indicate ear...ng cancer. , The researchers examined gene expr...with non-small cell lung cancer and a control grou...
Breaking Medicine News(10 mins):Health News:Serious Pregnancy Complication Detected With MRI 2Health News:National HIV Non-Profit Announces New Name 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Gene 'Signature' May Point to Lung Cancer 2
...benefits, but surgeons rethinking,one-size-fits-al...ients,who undergo foot and ankle surgery are recov...ks to new minimal incision techniques and tools. A...sions for the,sake of small incisions," says Lawre...
... LifeMasters Supported SelfCare,Inc., a national ... that it,has received an extension from the Center...sease management demonstration project in Florida....e,fee for service beneficiaries (Medicare/Medicaid...
...over the American Stroke Associations Internationa...08 at the Ernest N. Morial Convention Center in Ne...in the world of medical scientists and physicians ...ond year, the American Association of Neurological...
...Feb. 19 The Ensign,Group, Inc. (Nasdaq: ENSG ), ...led nursing, rehabilitative care services and assi...Park skilled nursing facility in,Tucson, Arizona h...p://www.newscom.com/cgi-bin/prnh/20071213/LATH168L...
...ary 19, 2008 New findings show that a specialized...ling genes can selectively target tumors in the br...sue remained virtually untouched, according to a F..., Most importantly, this study finds that the vir...
...rly Kent, the daughter of,Virginia Kent, Deceased,...urt for her mother,s death, which was caused by th...g Company immunity law is being challenged., All ...smissed and all Michigan victims were denied compe...
Other Medicine News:Health News:Surgeons Rethink Approach to Minimal Incision Foot and Ankle Surgery 2Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 2Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 3Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 2Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 3Health News:Tumor-killing virus selectively targets diseased brain cells 2Health News:Michigan Resident, Kimberly Kent's Drug Product Liability Case Will Be Argued in the United States Supreme Court on February 25, 2008 2
...rosol Resistant Tips offer a safe alternative to u... designed for applications such as PCR(a), pipetti...ddition, ART Tips are excellent for tissue culture...dies. ART Tips prevent aerosol contaminants and li...
Tipack (Sterilized) D1000
MBP 1000GGenomic Tip
...Premium Low Binding, Graduated, Long Reach Pipet T...d protein binding. Non-reactive. Beveled and refer...s up to 10 L. Produced & packaged completely by au...e Racked packaged 96 tips/rack and 10 racks/cs. AV...
Medicine Products: